Researchers discuss the history of endocrine therapies, highlights their adverse metabolic effects, and emphasizes the need for better biomarkers of diabetes.
In settling fraud case, New York Medicare Advantage insurer, CEO will pay up to $100M
A western New York health insurance provider for seniors and the CEO of its medical analytics arm have agreed to pay a total of up